Chronic pain is the leading cause of disability in the United States. The transition from acute to persistent pain is thought to arise from maladaptive neuroplastic mechanisms involving three intertwined processes, peripheral sensitization, central sensitization, and descending modulation. Strategies aimed at preventing persistent pain may target such processes. Models for studying preventive strategies include persistent…
European Journal of Pain Supplements Template
Write in a clean editor, then format for European Journal of Pain Supplements in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the European Journal of Pain Supplements format
European Journal of Pain Supplements is a peer-reviewed journal published by Elsevier, covering Pain Mechanisms and Treatments, Pain Management and Placebo Effect, Botulinum Toxin and Related Neurological Disorders.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, European Journal of Pain Supplements 12 (2023) 45–58.
Formats any DOI in European Journal of Pain Supplements style. No sign-up. |
| Publishes research in | Pain Mechanisms and Treatments Pain Management and Placebo Effect Botulinum Toxin and Related Neurological Disorders Pain Management and Opioid Use Anesthesia and Pain Management |
| ISSN | 1754-3207 |
| h-index | 15 |
| i10-index | 38 |
| Total citations | 1,632 |
| Top institutions publishing here | Policlinico San Matteo Fondazione |
| Journal website | www.clinicalkey.com.au |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in European Journal of Pain Supplements per year
Citation impact of European Journal of Pain Supplements by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in European Journal of Pain Supplements
Abstract Approximately 30% of patients experience persistent or recurrent low back and/or pain projecting into the legs following technically adequate lumbosacral surgery. Such pain conditions are often alluded to as the failed back surgery syndrome (FBSS). FBSS represents a significant clinical and economic concern. The treatment of FBSS presents a challenge to physicians, as conservative…
Cancer surgery still represents the main treatment indication for a large variety of cancers. At the time of surgery, an unknown number of dormant tumors may already exist distal to the primary cancer. At the same time, a large number of malignant circulating cells are released into the blood stream due to tumor manipulation. The…
Buprenorphine is a derivative of the morphine alkaloid thebaine. The plasma elimination half‐life of buprenorphine is three times longer than that of the active metabolite, norbuprenorphine. Although the elimination of norbuprenorphine from the body is more rapid than that of buprenorphine, the plasma concentration of norbuprenorphine was observed to exceed that of buprenorphine with chronic…
Fibromyalgia is a clinical syndrome of chronic widespread pain and reduced pain thresholds to palpation. The pathophysiology remains unknown, but there is increasing evidence that peripheral and central sensitization cause an amplification of sensory impulses that may alter pain perception in fibromyalgia patients. Interventions to treat fibromyalgia should aim at different targets simultaneously in order…